Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Not Confirmed
Not Confirmed
27 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
10 Nov 2021
// BUSINESSWIRE
https://www.businesswire.com/news/home/20211109006554/en/Bacthera-and-Seres-Therapeutics-Collaborate-for-Commercial-Manufacturing-of-SER-109-a-Potential-Treatment-Against-Recurrent-C.-difficile-Infection
27 Aug 2020
// PHARMAEXCIPIENTS
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9755
Submission : 1992-06-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9755
Submission : 1992-06-24
Status : Inactive
Type : II
Details:
AKS-452 is a protein subunit vaccine that is in Phase II testing at the University Medical Center Groningen (UMCG), one of the largest hospitals in the Netherlands.
Lead Product(s): Engineered SARS-CoV-2-RBD-Fc Fusion Protein Vaccine
Therapeutic Area: Infections and Infectious Diseases Brand Name: AKS-452
Study Phase: Phase I/ Phase IIProduct Type: Vaccine
Sponsor: Akston Biosciences
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement July 21, 2021
Lead Product(s) : Engineered SARS-CoV-2-RBD-Fc Fusion Protein Vaccine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I/ Phase II
Partner/Sponsor/Collaborator : Akston Biosciences
Deal Size : Undisclosed
Deal Type : Agreement
Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant to Formulate Aksto...
Details : AKS-452 is a protein subunit vaccine that is in Phase II testing at the University Medical Center Groningen (UMCG), one of the largest hospitals in the Netherlands.
Brand Name : AKS-452
Molecule Type : Vaccine
Upfront Cash : Undisclosed
July 21, 2021
Excipients
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24384
Submission : 2010-08-12
Status : Active
Type : IV
Certificate Number : R0-CEP 2000-310 - Rev 02
Issue Date : 2005-03-16
Type :
Substance Number :
Status : Withdrawn by Holder
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18925
Submission : 2005-11-01
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21266
Submission : 2008-01-18
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12524
Submission : 1997-06-02
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14031
Submission : 1999-03-08
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17578
Submission : 2004-07-30
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10870
Submission : 1994-04-14
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22091
Submission : 2008-10-15
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24398
Submission : 2010-09-09
Status : Active
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26300
Submission : 2012-07-24
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25438
Submission : 2011-10-25
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9756
Submission : 1992-06-24
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10870
Submission : 1994-04-14
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15895
Submission : 2002-03-12
Status : Inactive
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22091
Submission : 2008-10-15
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24384
Submission : 2010-08-12
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24398
Submission : 2010-09-09
Status : Active
Type : II
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26300
Submission : 2012-07-24
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27914
Submission : 2014-01-10
Status : Active
Type : IV
Excipients Web Link
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14031
Submission : 1999-03-08
Status : Active
Type : IV
Excipients Web Link
Excipients Web Link
Certificate Numbers : R0-CEP 2000-310 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2005-03-16
Type : TSE
Substance Number : 428
Excipients Web Link
Excipients by Ingredients
Application : Emulsifying Agents, Film Formers & Plasticizers, Topical
Excipient Details : Non-ionic lipophilic surfactant, emulsifier.
Pharmacopoeia Ref : Ph.Eur, USP-NF
Technical Specs : HLB: 9; EXCiPACT
Ingredient(s) : Sorbitan Laurate
Dosage Form : Injectable / Parenteral, Nasal Solution, Ophthalmic Solution
Grade : Injectable
Application : Parenteral
Excipient Details : Non-Ionic Lipophilic Surfactant, Emulsifier
Excipients By applications
Inspections and registrations
ABOUT THIS PAGE
Seppic is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of MONTANIDE ISA 708 bulk offered by Seppic
LOOKING FOR A SUPPLIER?